Page last updated: 2024-10-21

sk&f-38393 and Bradykinesia

sk&f-38393 has been researched along with Bradykinesia in 1 studies

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldberg, MS1
Pisani, A1
Haburcak, M1
Vortherms, TA1
Kitada, T1
Costa, C1
Tong, Y1
Martella, G1
Tscherter, A1
Martins, A1
Bernardi, G1
Roth, BL1
Pothos, EN1
Calabresi, P1
Shen, J1

Other Studies

1 other study available for sk&f-38393 and Bradykinesia

ArticleYear
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
    Neuron, 2005, Feb-17, Volume: 45, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Behavior, Animal;

2005